The key conclusion from such analysis is that in the first example (Figure 113) an aberrant plasma cell population (CD45-low, CD19-low, CD56+, lambda light chain restricted) can be identified in a multiple myeloma patient. This evidence concerns the gene CD19 and AL amyloidosis.